(Q42486771)

English

Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor-β1 expression in mesangial cells: biochemical and structural considerations

scientific article published on 14 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor-β1 expression in mesangial cells: biochemical and structural considerations (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Erwin Schleicher

4

object named as

Erwin D Schleicher

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

author name string

Magdalena Bacilieri

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Annamaria Naggi

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Monica Ceol

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Enrica Tosetto

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Maura Comoli

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Giangiacomo Torri

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Giovanni Gambaro

10

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

14 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1029-1037

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Transforming growth factor-beta in disease: the dark side of tissue repair

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Binding and growth-inhibitory effect of heparin and oligo-heparin (2kDa) in Balb/c 3T3 cells: lack of effect on PDGF- or serum-induced inositol lipid turnover

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Studies on heparin degradation. I. Preparation of ( 35 S) sulphamate derivatives for studies on heparin degrading enzymes of mammalian origin

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Order out of complexity--protein structures that interact with heparin

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Generation of anti-factor Xa active, 3-O-sulfated glucosamine-rich sequences by controlled desulfation of oversulfated heparins

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

"Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological properties

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Structural specificity of heparin binding in the fibroblast growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Modifications under basic conditions of the minor sequences of heparin containing 2,3 or 2,3,6 sulfatedd-glucosamine residues

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Antibodies against a putative heparin receptor slow cell proliferation and decrease MAPK activation in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

The disaccharides formed by deaminative cleavage of N-deacetylated glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Transforming growth factor beta as a therapeutic target in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWR038

21 January 2018

Identifiers

10.1093/GLYCOB/CWR038

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42486771&oldid=1959099600"